Current Enzyme Inhibition
Title:Meet Our Editor:
Volume: 11 Issue: 1
Author(s): Claudiu T. Supuran
Affiliation:
Export Options
About this article
Cite this article as:
T. Supuran Claudiu, Meet Our Editor:, Current Enzyme Inhibition 2015; 11 (1) . https://dx.doi.org/10.2174/157340801101150707123421
DOI https://dx.doi.org/10.2174/157340801101150707123421 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
24
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Linkage of Stress with Neuromuscular Disorders
CNS & Neurological Disorders - Drug Targets An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Anti-Cancer Agents in Medicinal Chemistry Aurora Kinase Family: A New Target for Anticancer Drug
Recent Patents on Anti-Cancer Drug Discovery Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry The Therapeutic Potential of RNA Interference: Novel Approaches for Cancer Treatment
Current Pharmaceutical Biotechnology Preface:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery Current Perspective in the International Trade of Medicinal Plants Material: An Update
Current Pharmaceutical Design Treatment of Acute Hypercalcemia
Medicinal Chemistry Association between MTHFR Gene Polymorphism and the Risk of Ovarian Cancer: A Meta-analysis of the Literature
Current Pharmaceutical Design Editorial: Novel microRNAs as Putative Therapeutic Targets in Cardiovascular Diseases
Current Vascular Pharmacology Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Current Gene Therapy Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases
Current Pharmaceutical Biotechnology Angiogenesis as a therapeutic target in breast cancer
Mini-Reviews in Medicinal Chemistry MicroRNAs as Cancer Biomarkers
MicroRNA HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo
Current Cancer Drug Targets